img

Global Generic Drugs Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Generic Drugs Market Insights, Forecast to 2034

A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.
Market Analysis and InsightsGlobal Generic Drugs Market
Global Generic Drugs market is expected to reach to US$ 341700 million in 2024, with a positive growth of %, compared with US$ 313470 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Generic Drugs industry is evaluated to reach US$ 551330 million in 2029. The CAGR will be 8.3% during 2024 to 2029.
Market competition is not intense. Teva, Novartis – Sandoz, Mylan, Sun Pharmaceutical and Aspen are the leaders of the industry, with about 19% market shares.
North America is the largest consumption place, with a consumption market share nearly 44%. Following North America, Europe is the second largest consumption place with the consumption market share of 18%.
Report Covers
This report presents an overview of global Generic Drugs market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Generic Drugs market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Teva
Novartis
Viatris
Sun Pharmaceutical
Aspen Pharmacare
Fresenius Kabi
Sanofi
Aurobindo
Lupin
Dr. Reddy's
Apotex
Cipla
ENDO
Stada Arzneimittel
Bausch Health
Hikma
Torrent
Glenmark
Piramal Pharma
Sawai Pharmaceutical
Segment by Type
Oral
Injection
Other

Segment by Application


Hospital Pharmacy
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Generic Drugs introduction, etc. Generic Drugs Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports’s Conclusions of Generic Drugs
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Generic Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Injection
1.2.4 Other
1.3 Market by Application
1.3.1 Global Generic Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Generic Drugs Market Perspective (2018-2029)
2.2 Global Generic Drugs Growth Trends by Region
2.2.1 Generic Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Generic Drugs Historic Market Size by Region (2018-2024)
2.2.3 Generic Drugs Forecasted Market Size by Region (2024-2029)
2.3 Generic Drugs Market Dynamics
2.3.1 Generic Drugs Industry Trends
2.3.2 Generic Drugs Market Drivers
2.3.3 Generic Drugs Market Challenges
2.3.4 Generic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Generic Drugs by Players
3.1.1 Global Generic Drugs Revenue by Players (2018-2024)
3.1.2 Global Generic Drugs Revenue Market Share by Players (2018-2024)
3.2 Global Generic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Generic Drugs, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Generic Drugs Market Concentration Ratio
3.4.1 Global Generic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Generic Drugs Revenue in 2022
3.5 Global Key Players of Generic Drugs Head office and Area Served
3.6 Global Key Players of Generic Drugs, Product and Application
3.7 Global Key Players of Generic Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Generic Drugs Breakdown Data by Type
4.1 Global Generic Drugs Historic Market Size by Type (2018-2024)
4.2 Global Generic Drugs Forecasted Market Size by Type (2024-2029)
5 Generic Drugs Breakdown Data by Application
5.1 Global Generic Drugs Historic Market Size by Application (2018-2024)
5.2 Global Generic Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Generic Drugs Market Size (2018-2029)
6.2 North America Generic Drugs Market Size by Type
6.2.1 North America Generic Drugs Market Size by Type (2018-2024)
6.2.2 North America Generic Drugs Market Size by Type (2024-2029)
6.2.3 North America Generic Drugs Market Share by Type (2018-2029)
6.3 North America Generic Drugs Market Size by Application
6.3.1 North America Generic Drugs Market Size by Application (2018-2024)
6.3.2 North America Generic Drugs Market Size by Application (2024-2029)
6.3.3 North America Generic Drugs Market Share by Application (2018-2029)
6.4 North America Generic Drugs Market Size by Country
6.4.1 North America Generic Drugs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Generic Drugs Market Size by Country (2018-2024)
6.4.3 North America Generic Drugs Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Generic Drugs Market Size (2018-2029)
7.2 Europe Generic Drugs Market Size by Type
7.2.1 Europe Generic Drugs Market Size by Type (2018-2024)
7.2.2 Europe Generic Drugs Market Size by Type (2024-2029)
7.2.3 Europe Generic Drugs Market Share by Type (2018-2029)
7.3 Europe Generic Drugs Market Size by Application
7.3.1 Europe Generic Drugs Market Size by Application (2018-2024)
7.3.2 Europe Generic Drugs Market Size by Application (2024-2029)
7.3.3 Europe Generic Drugs Market Share by Application (2018-2029)
7.4 Europe Generic Drugs Market Size by Country
7.4.1 Europe Generic Drugs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Generic Drugs Market Size by Country (2018-2024)
7.4.3 Europe Generic Drugs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Generic Drugs Market Size (2018-2029)
8.2 China Generic Drugs Market Size by Type
8.2.1 China Generic Drugs Market Size by Type (2018-2024)
8.2.2 China Generic Drugs Market Size by Type (2024-2029)
8.2.3 China Generic Drugs Market Share by Type (2018-2029)
8.3 China Generic Drugs Market Size by Application
8.3.1 China Generic Drugs Market Size by Application (2018-2024)
8.3.2 China Generic Drugs Market Size by Application (2024-2029)
8.3.3 China Generic Drugs Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Generic Drugs Market Size (2018-2029)
9.2 Asia Generic Drugs Market Size by Type
9.2.1 Asia Generic Drugs Market Size by Type (2018-2024)
9.2.2 Asia Generic Drugs Market Size by Type (2024-2029)
9.2.3 Asia Generic Drugs Market Share by Type (2018-2029)
9.3 Asia Generic Drugs Market Size by Application
9.3.1 Asia Generic Drugs Market Size by Application (2018-2024)
9.3.2 Asia Generic Drugs Market Size by Application (2024-2029)
9.3.3 Asia Generic Drugs Market Share by Application (2018-2029)
9.4 Asia Generic Drugs Market Size by Region
9.4.1 Asia Generic Drugs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Generic Drugs Market Size by Region (2018-2024)
9.4.3 Asia Generic Drugs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Generic Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Generic Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Generic Drugs Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Generic Drugs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Generic Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Generic Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Generic Drugs Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Generic Drugs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Generic Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Generic Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Generic Drugs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Generic Drugs Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Generic Drugs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Generic Drugs Introduction
11.1.4 Teva Revenue in Generic Drugs Business (2018-2024)
11.1.5 Teva Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Generic Drugs Introduction
11.2.4 Novartis Revenue in Generic Drugs Business (2018-2024)
11.2.5 Novartis Recent Developments
11.3 Viatris
11.3.1 Viatris Company Details
11.3.2 Viatris Business Overview
11.3.3 Viatris Generic Drugs Introduction
11.3.4 Viatris Revenue in Generic Drugs Business (2018-2024)
11.3.5 Viatris Recent Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Details
11.4.2 Sun Pharmaceutical Business Overview
11.4.3 Sun Pharmaceutical Generic Drugs Introduction
11.4.4 Sun Pharmaceutical Revenue in Generic Drugs Business (2018-2024)
11.4.5 Sun Pharmaceutical Recent Developments
11.5 Aspen Pharmacare
11.5.1 Aspen Pharmacare Company Details
11.5.2 Aspen Pharmacare Business Overview
11.5.3 Aspen Pharmacare Generic Drugs Introduction
11.5.4 Aspen Pharmacare Revenue in Generic Drugs Business (2018-2024)
11.5.5 Aspen Pharmacare Recent Developments
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Details
11.6.2 Fresenius Kabi Business Overview
11.6.3 Fresenius Kabi Generic Drugs Introduction
11.6.4 Fresenius Kabi Revenue in Generic Drugs Business (2018-2024)
11.6.5 Fresenius Kabi Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Generic Drugs Introduction
11.7.4 Sanofi Revenue in Generic Drugs Business (2018-2024)
11.7.5 Sanofi Recent Developments
11.8 Aurobindo
11.8.1 Aurobindo Company Details
11.8.2 Aurobindo Business Overview
11.8.3 Aurobindo Generic Drugs Introduction
11.8.4 Aurobindo Revenue in Generic Drugs Business (2018-2024)
11.8.5 Aurobindo Recent Developments
11.9 Lupin
11.9.1 Lupin Company Details
11.9.2 Lupin Business Overview
11.9.3 Lupin Generic Drugs Introduction
11.9.4 Lupin Revenue in Generic Drugs Business (2018-2024)
11.9.5 Lupin Recent Developments
11.10 Dr. Reddy's
11.10.1 Dr. Reddy's Company Details
11.10.2 Dr. Reddy's Business Overview
11.10.3 Dr. Reddy's Generic Drugs Introduction
11.10.4 Dr. Reddy's Revenue in Generic Drugs Business (2018-2024)
11.10.5 Dr. Reddy's Recent Developments
11.11 Apotex
11.11.1 Apotex Company Details
11.11.2 Apotex Business Overview
11.11.3 Apotex Generic Drugs Introduction
11.11.4 Apotex Revenue in Generic Drugs Business (2018-2024)
11.11.5 Apotex Recent Developments
11.12 Cipla
11.12.1 Cipla Company Details
11.12.2 Cipla Business Overview
11.12.3 Cipla Generic Drugs Introduction
11.12.4 Cipla Revenue in Generic Drugs Business (2018-2024)
11.12.5 Cipla Recent Developments
11.13 ENDO
11.13.1 ENDO Company Details
11.13.2 ENDO Business Overview
11.13.3 ENDO Generic Drugs Introduction
11.13.4 ENDO Revenue in Generic Drugs Business (2018-2024)
11.13.5 ENDO Recent Developments
11.14 Stada Arzneimittel
11.14.1 Stada Arzneimittel Company Details
11.14.2 Stada Arzneimittel Business Overview
11.14.3 Stada Arzneimittel Generic Drugs Introduction
11.14.4 Stada Arzneimittel Revenue in Generic Drugs Business (2018-2024)
11.14.5 Stada Arzneimittel Recent Developments
11.15 Bausch Health
11.15.1 Bausch Health Company Details
11.15.2 Bausch Health Business Overview
11.15.3 Bausch Health Generic Drugs Introduction
11.15.4 Bausch Health Revenue in Generic Drugs Business (2018-2024)
11.15.5 Bausch Health Recent Developments
11.16 Hikma
11.16.1 Hikma Company Details
11.16.2 Hikma Business Overview
11.16.3 Hikma Generic Drugs Introduction
11.16.4 Hikma Revenue in Generic Drugs Business (2018-2024)
11.16.5 Hikma Recent Developments
11.17 Torrent
11.17.1 Torrent Company Details
11.17.2 Torrent Business Overview
11.17.3 Torrent Generic Drugs Introduction
11.17.4 Torrent Revenue in Generic Drugs Business (2018-2024)
11.17.5 Torrent Recent Developments
11.18 Glenmark
11.18.1 Glenmark Company Details
11.18.2 Glenmark Business Overview
11.18.3 Glenmark Generic Drugs Introduction
11.18.4 Glenmark Revenue in Generic Drugs Business (2018-2024)
11.18.5 Glenmark Recent Developments
11.19 Piramal Pharma
11.19.1 Piramal Pharma Company Details
11.19.2 Piramal Pharma Business Overview
11.19.3 Piramal Pharma Generic Drugs Introduction
11.19.4 Piramal Pharma Revenue in Generic Drugs Business (2018-2024)
11.19.5 Piramal Pharma Recent Developments
11.20 Sawai Pharmaceutical
11.20.1 Sawai Pharmaceutical Company Details
11.20.2 Sawai Pharmaceutical Business Overview
11.20.3 Sawai Pharmaceutical Generic Drugs Introduction
11.20.4 Sawai Pharmaceutical Revenue in Generic Drugs Business (2018-2024)
11.20.5 Sawai Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Generic Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Key Players of Other
Table 5. Global Generic Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Generic Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Generic Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Generic Drugs Market Share by Region (2018-2024)
Table 9. Global Generic Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Generic Drugs Market Share by Region (2024-2029)
Table 11. Generic Drugs Market Trends
Table 12. Generic Drugs Market Drivers
Table 13. Generic Drugs Market Challenges
Table 14. Generic Drugs Market Restraints
Table 15. Global Generic Drugs Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Generic Drugs Revenue Share by Players (2018-2024)
Table 17. Global Top Generic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Drugs as of 2022)
Table 18. Global Generic Drugs Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Generic Drugs Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Generic Drugs, Headquarters and Area Served
Table 21. Global Key Players of Generic Drugs, Product and Application
Table 22. Global Key Players of Generic Drugs, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Generic Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Generic Drugs Revenue Market Share by Type (2018-2024)
Table 26. Global Generic Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Generic Drugs Revenue Market Share by Type (2024-2029)
Table 28. Global Generic Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Generic Drugs Revenue Share by Application (2018-2024)
Table 30. Global Generic Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Generic Drugs Revenue Share by Application (2024-2029)
Table 32. North America Generic Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Generic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Generic Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Generic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Generic Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Generic Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Generic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Generic Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Generic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Generic Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Generic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Generic Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Generic Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Generic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Generic Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Generic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Generic Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Generic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Generic Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Generic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Generic Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Generic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Generic Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Generic Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Generic Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Generic Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Generic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Generic Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Generic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Generic Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Generic Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Generic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 64. Teva Company Details
Table 65. Teva Business Overview
Table 66. Teva Generic Drugs Product
Table 67. Teva Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 68. Teva Recent Developments
Table 69. Novartis Company Details
Table 70. Novartis Business Overview
Table 71. Novartis Generic Drugs Product
Table 72. Novartis Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 73. Novartis Recent Developments
Table 74. Viatris Company Details
Table 75. Viatris Business Overview
Table 76. Viatris Generic Drugs Product
Table 77. Viatris Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 78. Viatris Recent Developments
Table 79. Sun Pharmaceutical Company Details
Table 80. Sun Pharmaceutical Business Overview
Table 81. Sun Pharmaceutical Generic Drugs Product
Table 82. Sun Pharmaceutical Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 83. Sun Pharmaceutical Recent Developments
Table 84. Aspen Pharmacare Company Details
Table 85. Aspen Pharmacare Business Overview
Table 86. Aspen Pharmacare Generic Drugs Product
Table 87. Aspen Pharmacare Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 88. Aspen Pharmacare Recent Developments
Table 89. Fresenius Kabi Company Details
Table 90. Fresenius Kabi Business Overview
Table 91. Fresenius Kabi Generic Drugs Product
Table 92. Fresenius Kabi Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 93. Fresenius Kabi Recent Developments
Table 94. Sanofi Company Details
Table 95. Sanofi Business Overview
Table 96. Sanofi Generic Drugs Product
Table 97. Sanofi Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 98. Sanofi Recent Developments
Table 99. Aurobindo Company Details
Table 100. Aurobindo Business Overview
Table 101. Aurobindo Generic Drugs Product
Table 102. Aurobindo Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 103. Aurobindo Recent Developments
Table 104. Lupin Company Details
Table 105. Lupin Business Overview
Table 106. Lupin Generic Drugs Product
Table 107. Lupin Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 108. Lupin Recent Developments
Table 109. Dr. Reddy's Company Details
Table 110. Dr. Reddy's Business Overview
Table 111. Dr. Reddy's Generic Drugs Product
Table 112. Dr. Reddy's Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 113. Dr. Reddy's Recent Developments
Table 114. Apotex Company Details
Table 115. Apotex Business Overview
Table 116. Apotex Generic Drugs Product
Table 117. Apotex Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 118. Apotex Recent Developments
Table 119. Cipla Company Details
Table 120. Cipla Business Overview
Table 121. Cipla Generic Drugs Product
Table 122. Cipla Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 123. Cipla Recent Developments
Table 124. ENDO Company Details
Table 125. ENDO Business Overview
Table 126. ENDO Generic Drugs Product
Table 127. ENDO Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 128. ENDO Recent Developments
Table 129. Stada Arzneimittel Company Details
Table 130. Stada Arzneimittel Business Overview
Table 131. Stada Arzneimittel Generic Drugs Product
Table 132. Stada Arzneimittel Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 133. Stada Arzneimittel Recent Developments
Table 134. Bausch Health Company Details
Table 135. Bausch Health Business Overview
Table 136. Bausch Health Generic Drugs Product
Table 137. Bausch Health Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 138. Bausch Health Recent Developments
Table 139. Hikma Company Details
Table 140. Hikma Business Overview
Table 141. Hikma Generic Drugs Product
Table 142. Hikma Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 143. Hikma Recent Developments
Table 144. Torrent Company Details
Table 145. Torrent Business Overview
Table 146. Torrent Generic Drugs Product
Table 147. Torrent Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 148. Torrent Recent Developments
Table 149. Glenmark Company Details
Table 150. Glenmark Business Overview
Table 151. Glenmark Generic Drugs Product
Table 152. Glenmark Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 153. Glenmark Recent Developments
Table 154. Piramal Pharma Company Details
Table 155. Piramal Pharma Business Overview
Table 156. Piramal Pharma Generic Drugs Product
Table 157. Piramal Pharma Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 158. Piramal Pharma Recent Developments
Table 159. Sawai Pharmaceutical Company Details
Table 160. Sawai Pharmaceutical Business Overview
Table 161. Sawai Pharmaceutical Generic Drugs Product
Table 162. Sawai Pharmaceutical Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 163. Sawai Pharmaceutical Recent Developments
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Generic Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Generic Drugs Market Share by Type: 2022 VS 2029
Figure 3. Oral Features
Figure 4. Injection Features
Figure 5. Other Features
Figure 6. Global Generic Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Generic Drugs Market Share by Application: 2022 VS 2029
Figure 8. Hospital Pharmacy Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Other Case Studies
Figure 11. Generic Drugs Report Years Considered
Figure 12. Global Generic Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Generic Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Generic Drugs Market Share by Region: 2022 VS 2029
Figure 15. Global Generic Drugs Market Share by Players in 2022
Figure 16. Global Top Generic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Drugs as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Generic Drugs Revenue in 2022
Figure 18. North America Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Generic Drugs Market Share by Type (2018-2029)
Figure 20. North America Generic Drugs Market Share by Application (2018-2029)
Figure 21. North America Generic Drugs Market Share by Country (2018-2029)
Figure 22. United States Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Generic Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Generic Drugs Market Share by Type (2018-2029)
Figure 26. Europe Generic Drugs Market Share by Application (2018-2029)
Figure 27. Europe Generic Drugs Market Share by Country (2018-2029)
Figure 28. Germany Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Generic Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Generic Drugs Market Share by Type (2018-2029)
Figure 36. China Generic Drugs Market Share by Application (2018-2029)
Figure 37. Asia Generic Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Generic Drugs Market Share by Type (2018-2029)
Figure 39. Asia Generic Drugs Market Share by Application (2018-2029)
Figure 40. Asia Generic Drugs Market Share by Region (2018-2029)
Figure 41. Japan Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Generic Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Generic Drugs Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Generic Drugs Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Generic Drugs Market Share by Country (2018-2029)
Figure 51. Brazil Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Teva Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 58. Novartis Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 59. Viatris Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 60. Sun Pharmaceutical Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 61. Aspen Pharmacare Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 62. Fresenius Kabi Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 63. Sanofi Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 64. Aurobindo Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 65. Lupin Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 66. Dr. Reddy's Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 67. Apotex Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 68. Cipla Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 69. ENDO Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 70. Stada Arzneimittel Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 71. Bausch Health Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 72. Hikma Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 73. Torrent Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 74. Glenmark Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 75. Piramal Pharma Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 76. Sawai Pharmaceutical Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries